Status:
COMPLETED
Art and Physical Therapy in Pediatric HCT
Lead Sponsor:
Medical University of South Carolina
Collaborating Sponsors:
National Endowment for the Arts, United States
Conditions:
Hematopoietic Stem Cell Transplantation
Art Therapy
Eligibility:
All Genders
5-18 years
Phase:
NA
Brief Summary
The purpose of this study is to compare the effect of a combination of art therapy (AT) and physical therapy (PT) to PT only in children undergoing hematopoietic cell transplant (HCT). Each child will...
Detailed Description
This quantitative randomized clinical trial will examine the effect of a collaborative art therapy (AT) and physical therapy (PT) intervention as compared to a PT only intervention in children undergo...
Eligibility Criteria
Inclusion
- between ages 5 to 18
- Clinical Diagnosis of hematological disease
- Undergoing Hematopoietic Cell Transplantation (HCT)
- Within the inpatient hospital treatment phase of HCT
Exclusion
- Less than age 5
- Older than age 18
- Central nervous system impairments (e.g., cerebral palsy)
- Genetic diseases (e.g., Down syndrome)
- Cognitive impairment
Key Trial Info
Start Date :
October 12 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 31 2024
Estimated Enrollment :
18 Patients enrolled
Trial Details
Trial ID
NCT05441670
Start Date
October 12 2022
End Date
December 31 2024
Last Update
January 17 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
MUSC Shawn Jenkin's Children's Hospital
Charleston, South Carolina, United States, 29425